ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+3.42%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$327M
AUM Growth
+$327M
(+0.32%)
Cap. Flow
-$6.22M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
106
New
22
Increased
29
Reduced
23
Closed
31
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$10.6M |
| 2 |
Medtronic
MDT
|
$7.15M |
| 3 |
Merck
MRK
|
$5.97M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$5.9M |
| 5 |
AGN
Allergan plc
AGN
|
$5.89M |
Top Sells
| 1 |
Pfizer
PFE
|
$8.12M |
| 2 |
Universal Health Services
UHS
|
$7.89M |
| 3 |
Biogen
BIIB
|
$7.78M |
| 4 |
BCR
CR Bard Inc.
BCR
|
$5.49M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$4.77M |
Sector Composition
| 1 | Healthcare | 86.13% |
| 2 | Real Estate | 3.64% |
| 3 | Financials | 2.17% |
| 4 | Technology | 0.3% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ascendis Pharma
ASND
$11.8B
| $1.52M | 0.46% |
37,828
+20,498
| +118% | +$821K |
|
52
Tactile Systems Technology
TCMD
$297M
| $1.48M | 0.45% |
+50,900
| New | +$1.48M |
|
53
Edwards Lifesciences
EW
$47.8B
| $1.38M | 0.42% |
12,216
+600
| +5% | +$67.6K |
|
|
IMGN
54
DELISTED
Immunogen Inc
IMGN
| $1.35M | 0.41% |
210,800
+132,300
| +169% | +$848K |
|
|
RDUS
55
DELISTED
Radius Health, Inc.
RDUS
| $1.32M | 0.4% |
41,400
+30,900
| +294% | +$981K |
|
|
MDCO
56
DELISTED
Medicines Co
MDCO
| $1.13M | 0.34% |
+41,200
| New | +$1.13M |
|
|
VCRA
57
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $982K | 0.3% |
+32,500
| New | +$982K |
|
58
AnaptysBio
ANAB
$569M
| $977K | 0.3% |
9,700
-14,900
| -61% | -$1.5M |
|
|
RNTX
59
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $906K | 0.28% |
85,997
+16,647
| +24% | +$175K |
|
60
BioMarin Pharmaceuticals
BMRN
$11.2B
| $901K | 0.28% |
+10,100
| New | +$901K |
|
|
AKTX
61
Akari Therapeutics
AKTX
$24.8M
| $871K | 0.27% |
+201,097
| New | +$871K |
|
|
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
| $801K | 0.24% |
+20,000
| New | +$801K |
|
63
Insmed
INSM
$28.8B
| $714K | 0.22% |
22,910
-72,490
| -76% | -$2.26M |
|
64
Incyte
INCY
$16.5B
| $703K | 0.21% |
7,420
-14,180
| -66% | -$1.34M |
|
65
Revvity
RVTY
$10.5B
| $688K | 0.21% |
+9,405
| New | +$688K |
|
66
Jazz Pharmaceuticals
JAZZ
$7.75B
| $667K | 0.2% |
4,950
-13,500
| -73% | -$1.82M |
|
|
ARRY
67
DELISTED
Array Biopharma Inc
ARRY
| $648K | 0.2% |
50,600
-40,400
| -44% | -$517K |
|
|
OMED
68
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $570K | 0.17% |
+139,100
| New | +$570K |
|
69
Assembly Biosciences
ASMB
$190M
| $430K | 0.13% |
+9,500
| New | +$430K |
|
70
Cigna
CI
$80.3B
| $406K | 0.12% |
2,000
-14,700
| -88% | -$2.98M |
|
71
Apellis Pharmaceuticals
APLS
$3.48B
| $382K | 0.12% |
+17,600
| New | +$382K |
|
72
Spero Therapeutics
SPRO
$116M
| $365K | 0.11% |
+31,100
| New | +$365K |
|
|
BHVN
73
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $278K | 0.09% |
+10,300
| New | +$278K |
|
|
DRNA
74
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $170K | 0.05% |
+18,837
| New | +$170K |
|
75
ANI Pharmaceuticals
ANIP
$2.03B
| – | – |
-59,900
| Closed | -$3.14M |
|